We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Pectin From Citrus Fruit Could Prove To Be Weapon Against Prostate Cancer

July 2, 2010: 12:23 PM EST
In lab tests of human and mouse prostate cancer cell lines, modified citrus pectin (MCP)inhibits cell proliferation and induces cell death (apoptosis) in both hormone-sensitive and hormone-resistant cancer cells. MCP is extracted from the pith of citrus fruit. It is then tailored to meet specific molecular chain and weight requirements. The U.S. scientists said the data indicate that MCP adheres to galectin proteins and prevents cancer cells from sticking to each other and to the inner walls of blood vessels. That, in turn, halts or slows tumor growth and growth of new blood vessels. MCP’s safety and ability to act without hormonal mechanisms “makes it an excellent agent to be used in conjunction with other therapies," one researcher said.
Yan J, Katz AE, "PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and Independent Prostate Cancer Cells", Integrative Cancer Therapies, July 02, 2010, © Sage Publications
Vitality & Better Living
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.